Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2014 Financial
Results and Conference Call
PETALUMA, Calif., May 29, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences,
Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal
fourth quarter 2014, ended March 31, 2014, will be released after the U.S.
markets close on June 12, 2014. The earnings release will be followed by a
conference call at 1:30 p.m. PDT (4:30 p.m. EDT) on June 12, 2014, to discuss
fiscal fourth quarter and year-end results.
Individuals interested in participating in the conference call may do so by
dialing 877-303-7607 for domestic callers or 973-638-3203 for international
callers. Those interested in listening to the conference call live via the
internet may do so at http://ir.oculusis.com/events.cfm. Please log on
approximately 30 minutes prior to the presentation in order to register and
download the appropriate software.
A telephone replay will be available for seven days following the conclusion
of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for
international callers, and entering conference code 46958307. A webcast replay
will be available on the site at http://ir.oculusis.com/events.cfm for one
year following the call.
About Oculus Innovative Sciences
Oculus Innovative Sciences is a global healthcare company that designs,
manufactures and marketsprescription and non-prescription products in 33
countries. The company's products are used to treat patients in
surgical/advanced wound management, dermatology, women's health and animal
health; addressing the unmet medical needs of these markets—while raising the
standard ofpatient care and lowering overall healthcare costs. The company's
headquarters are in Petaluma, California, with manufacturing operations in the
United States and Latin America. More information can be found
CONTACT: Media and Investor Contact:
Oculus Innovative Sciences, Inc.
VP of Public and Investor Relations
Press spacebar to pause and continue. Press esc to stop.